
Long Covid: Probiotics could form a potential treatment
Globally, it is estimated to have affected some 400 million individuals who experience lingering symptoms such as brain fog, digestive issues and general malaise.
In an attempt to find a solution, a team of researchers from the Chinese University of Hong Kong (CUHK) decided to assess a symbiotic preparation (a formulation that combines probiotics and prebiotics) to see if it could alleviate long Covid symptoms.
This is as previous CUHK studies had shown that long Covid patients had altered gut microbiomes.
Their formulation was developed based on a decade of research on Asian gut microbiomes.
It consists of three probiotics ( Bifidobacterium adolescentis , Bifidobacterium longum and Bifidobacterium bifidum ) and three prebiotic fibres (galactooligosaccharides, xylooligosaccharides and resistant dextrin).
From 2021 to 2022, 463 recovered patients with at least one long Covid symptom were recruited for the randomised controlled trial in Hong Kong.
Nearly 70% were suspected to have been infected with the SARS-CoV-2 Omicron variant.
The patients were randomly assigned to receive either the formulation or a placebo containing low dose Vitamin C for six months.
At the end of the study, 70% of the former reported improvement in digestive problems, compared to 54.1% in the placebo group.
The group taking the formulation also had more improvements for symptoms like fatigue, difficulty in concentration, memory loss and general unwellness, compared to those taking the placebo.
Analysis of their stool also showed that the formulation resulted in increased bacteria diversity, increased abundance of 'favourable' bacteria, and reduced abundance of 'unfavourable' bacteria in the gut.
'To our knowledge, this is the first clinical trial to show that modulation of the gut microbiome can improve long Covid symptoms, including memory and concentration problems.
'These data support the importance of the gut-brain axis.
'Restoring a healthy gut microbiota is a novel approach to improve neurological symptoms via the production of beneficial metabolites from gut bacteria that circulate to the brain to improve brain function,' says study lead investigator and gastroenterologist Professor Dr Siew C. Ng.
The groundbreaking research was published in the March 2024 issue of the Lancet Infectious Diseases journal.
'We've seen that gut bacteria colonisation takes about six to 12 months to happen, so I tell my patients to take the formulation for a minimum of six months.
'If symptoms improve, they can come off it.
'A small proportion of them can do this, but over time, the bacteria may drop depending on diet, whether you received antibiotics, etc.
'However, a lot of patients are still on it after three years as they reported that once they stopped taking it, some of their symptoms returned.
'There is really no one-size-fits-all approach,' she says in a recent interview.
Probiotic supplements are generally taken for health benefits, but if you're already healthy, do you need them?
Prof Ng says: 'It's all right to be sceptical of probiotics as there are so many out there that claim to work.
'You're taking them for prevention, but it makes no difference if you're healthy as you won't know if it is working!'
The associate dean of CUHK's Faculty of Medicine, who has been doing probiotics research for decades, is on a mission to educate doctors and pharmacists on how to choose or prescribe probiotics.
'Personally, I need scientific back-up to gauge the effectiveness of probiotics.
'We have isolated strains in our laboratory and know that not all of them have equal benefits.
'We've done clinical studies that showed no difference in gut microbiota when you take some of them.
'My advice to the public is to first try lifestyle measures to modulate the gut before taking probiotics.
'Then look at the large clinical studies and digest the information before deciding if you really need these supplements,' she says, adding that their formulation is now available in selected pharmacies in Malaysia.
Click here for more on CUHK's research on restoring the gut microbiota to address eczema in children.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Star
6 hours ago
- The Star
More British babies born via IVF, showing changing landscape of fertility care
IVF births in Britain have increased from 1.3% in 2000 to 3.1% in 2023. Photo: Freepik The equivalent of almost one child in every classroom in Britain is now born as a result of in-vitro fertilisation or IVF fertility treatment, new figures suggest. Almost 21,000 babies were born from IVF in 2023, compared to 8,700 in 2000, the Human Fertilisation and Embryology Authority (HFEA) said. The authors of the fertility regulator's latest report wrote: "IVF births are making up a higher proportion of all British births over time, increasing from 1.3% in 2000 to 3.1% in 2023. "This means around one in 32 British births in 2023 were via IVF – roughly one child in every classroom – compared to one in 43 in 2013.' The HFEA said that its latest figures show the "changing landscape' of fertility care in Britain. Overall, 52,400 patients had ,ore than 77,500 in vitro fertilisation (IVF) cycles at British fertility clinics in 2023. Some 11% of births to women aged 40-44 were a result of IVF, increasing from 4% in 2000 and accounting for 0.5% of all births, HFEA said. The data also reveal a rise in the proportion of women freezing their eggs – a rise from 4,700 in 2022 to 6,900 in 2023 – but the HFEA said that the number of patients using their stored frozen eggs in treatment remains "low.' Meanwhile the HFEA also said that in 2023, around 820 babies were born following donor insemination (DI) treatment. The figures also show a reduction in the number of IVF treatments funded by the NHS. The proportion of NHS-funded IVF cycles declined from 35% in 2019 to 27% in 2023. Racial disparities The HFEA also raised concerns about racial disparities in IVF. It said that in recent years, Asian and Black patients have had lower birth rates compared to white patients and those from a mixed ethnic background. Julia Chain, chairwoman of the HFEA, said: "IVF is helping more people have babies including patients of different ages and family types. "One in 32 of all British births are from IVF and 11% of all UK births are to women aged 40-44 who had IVF. "These findings highlight the changing landscape of the fertility sector and how it could develop in the years to come. "However, we are very concerned to see that Black and Asian patients continue to have lower IVF birth rates compared to other patient groups, and our recent survey found that Asian and Black patients are less likely to report being satisfied with their fertility treatment.' Data from the Office for National Statistics show that the fertility rate in England and Wales in 2023 was 1.44 children per woman – the lowest level on record. Commenting on the HFEA data, a spokesperson from the fertility charity Fertility Network UK said: "This important report from the HFEA reflects how essential fertility treatment has become for growing families and underlines not just the scientific advances in fertility care, but also the profound social impact of helping people realise their dreams of parenthood. "Delays in accessing treatment – whether due to long GP referral times or inconsistent NHS funding – can have a devastating emotional and biological impact. We call for fair and timely access to fertility services for all, wherever they live and whatever their background.' – dpa


The Sun
9 hours ago
- The Sun
Vacancies at public healthcare facilities to be filled soon
PETALING JAYA: The government will expedite the filling of 4,352 positions at public healthcare facilities by the end of this year, with priority given to contract doctors, said Prime Minister Datuk Seri Anwar Ibrahim. He said immediate steps are needed to strengthen the country's healthcare delivery. 'There have been complaints about critical vacancies, particularly involving doctors. So, we have decided that while services must improve, there is also a clear need to bring in new and contract doctors,' he said during a televised address to the nation yesterday. He said Malaysia's economic trajectory remains 'strong and convincing', a sentiment reflected in both domestic indicators and positive global assessments. 'The ringgit's value reflects growing confidence, having strengthened by over 5% against the US dollar as of mid-year. The ringgit currently stands at RM4.23, placing it among the top five performing Asian currencies this year. 'GDP growth for the first quarter stood at 4.4%, and based on early estimates, the second quarter is expected to reach 4.5%. 'Malaysia climbed 11 spots to 23rd place in the International Institute for Management Development World Competitiveness Ranking 2025. 'Last year, we recorded the highest approved investments in history at RM384 billion, a 17% increase from 2023, and this figure is expected to rise further this year.'


The Sun
15 hours ago
- The Sun
WHO denies US claims of violating national sovereignty in pandemic rules
GENEVA: The World Health Organization has firmly denied US allegations that recent amendments to global health regulations infringe on national sovereignty. WHO Director-General Tedros Adhanom Ghebreyesus clarified that the organization only provides guidance, leaving implementation entirely to member states. 'Our job is to provide evidence-based recommendations and guidelines, and to support countries to protect and improve the health of their populations,' Tedros stated. 'But how or whether countries implement that advice has always been and always will be up to them, based on their national guidelines and rules.' The amendments to the International Health Regulations (IHR), approved in 2024, introduced a 'pandemic emergency' alert level to enable faster global coordination. These changes followed criticism of delayed responses during the COVID-19 crisis. However, the US administration, led by President Donald Trump, rejected the revisions last week. Secretary of State Marco Rubio and Health Secretary Robert F. Kennedy argued that the rules could undermine national decision-making. 'We will put Americans first in all our actions and we will not tolerate international policies that infringe on Americans' speech, privacy or personal liberties,' they said in a joint statement. Tedros emphasized that the amendments were developed and adopted by member states, not imposed by the WHO. 'WHO has no authority to tell countries what to do. We cannot impose travel bans, lockdowns, vaccine mandates or any other type of measure. Nor do we seek to,' he said. Steven Solomon, WHO's chief legal officer, confirmed that only a few countries opposed the changes before the July 19 deadline. 'It's now clear that the 2024 IHR amendments will apply to the overwhelming majority of the 196 countries that are party to the IHRs,' he said. - AFP